Weekly Icodec Therapy and Glargine Similarly Lower Blood Glucose Levels in T2D
Investigators compared glucose-lowering efficacy and safety profile of once-weekly treatment with insulin icodec and once-daily insulin glargine U100 in patients with type 2 diabetes.